@article{9d51ce72f33a4d53be71035d2e872815,
title = "Challenges in the management of the transgender patient with sickle cell disease",
author = "Jocelyn Ronda and Anne Nord and Renata Arrington-Sanders and Rakhi Naik and Takemoto, {Clifford M.} and Jacquelyn Baskin and Sophie Lanzkron and Pecker, {Lydia H.}",
note = "Funding Information: We are grateful to our patients for inspiring us to learn more and for their willingness to be included in this report. J.R. was supported by National Institutes of Health grants (T32HD044355, T32HD052459) during her fellowship in adolescent medicine at Johns Hopkins. R.A.S. is supported by a National Institutes of Health, National Institute of Drug Abuse Grant (R01DA043089-02). R.N. is supported by a National Heart, Lung and Blood Institute Grant (K08HL125100). C.T. receives funding from Novo Nordisk and Alnylam Pharmaceuticals and serves on the Data Safety Monitoring Board for Novartis and the Advisory Board for Genentech.",
year = "2018",
month = nov,
doi = "10.1002/ajh.25242",
language = "English (US)",
volume = "93",
pages = "E360--E362",
journal = "American journal of hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "11",
}